tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cathie Wood Sells Tesla (TSLA) Stock, and Buys This Stock after Q3 Beat

Cathie Wood Sells Tesla (TSLA) Stock, and Buys This Stock after Q3 Beat

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Friday, November 7, according to daily fund disclosures. The standout moves included a major Tesla (TSLA) sale and a sizable buy in The Trade Desk (TTD) stock following the digital ad platform’s better-than-expected Q3.

Meet Your ETF AI Analyst

Wood Sells Tesla, GitLab, and Roku

The biggest sale came from Tesla (TSLA), as ARK offloaded 71,638 shares worth about $31.94 million. This marks another step in ARK’s ongoing reduction of its Tesla holdings. The sale came at the same time CEO Elon Musk’s record-breaking $1 trillion pay package won shareholder approval.

ARK also sold 236,749 shares of GitLab (GTLB) for around $10.79 million. The move follows other recent sales as the fund reduces its exposure to software names. Another large sale came from Roku (ROKU), where ARK offloaded 84,988 shares worth roughly $8.91 million.

ARK Buys Trade Desk amid Strong Q3 Earnings Report

On the buying side, ARK made a big move into The Trade Desk (TTD), adding 316,072 shares worth about $14.51 million. The buy shows ARK’s interest in the digital ad market, which continues to grow as brands shift more spending online.

ARK’s move aligns with the company’s strong third-quarter results, which showed revenue of $739 million, up 18% year-over-year, and adjusted earnings of $0.45 per share, both above estimates.

ARK also added 1,046,699 shares of Intellia Therapeutics (NTLA), valued at about $12.90 million. The firm has been building its stake in the gene-editing company all week, signaling strong confidence in biotech innovation. In smaller buys, ARK purchased shares of Beam Therapeutics (BEAM) worth about $4.28 million and Twist Bioscience (TWST) worth roughly $4.00 million.

Let’s see how these stocks perform using the TipRanks Stock Comparison Tool:

Disclaimer & DisclosureReport an Issue

1